NIH-funded research R21 grant

Neuroinflammation as a Target to Protect Thinking in Heart Failure Patients

Official title: Neuroinflammation as a Therapeutic Target in Heart Failure-Related Cognitive Decline: A Feasibility PET Study

Funded at State University New York Stony Brook · NIH-11439425 · Data updated 2026-11-12

A small feasibility study will test whether a brain scan can show that a heart-failure treatment reduces brain inflammation and protects thinking skills in people with heart failure and cognitive concerns.

More Heart Failure research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startAugust 5, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$436,001
NIH project number1R21AG102953-01
Project IDNIH-11439425 on NIH RePORTER

Who could benefit from this research

Could help

Adults with heart failure who show signs of cognitive impairment or are at risk for vascular cognitive decline.

Less likely to help

Patients without heart failure or cognitive concerns are unlikely to benefit from these findings.

What this research studies

This project will use a new PET brain scan to measure inflammation in people with heart failure who also have or are at risk for cognitive problems. We will look at the effects of sacubitril-valsartan on brain inflammation by imaging with the [11C]PS13 radioligand, aiming to link inflammation changes with cognitive outcomes. If successful, the study will set the stage for larger trials to prevent or slow vascular-related cognitive decline in cardiovascular disease. Participation will involve brain imaging and standard clinical assessments over a defined period. The work is designed to generate proof-of-concept data on whether reducing brain inflammation could protect cognition in heart failure patients.

Why it matters

Potential benefit: Finding a way to reduce brain inflammation could help preserve memory and thinking in people with heart failure.

How similar studies have gone: Previous observational data suggest anti-inflammatory effects may link to better cognitive outcomes, but this specific imaging approach is an early, feasibility step.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Kalogeropoulos, Andreas — State University New York Stony Brook
  • Study coordinator: Kalogeropoulos, Andreas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.